trending Market Intelligence /marketintelligence/en/news-insights/trending/ikfak80yi9qcpzs474ftbg2 content esgSubNav
In This List

Bellicum Pharmaceuticals adds former Pfizer exec to board

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Bellicum Pharmaceuticals adds former Pfizer exec to board

Houston-based biotech company Bellicum Pharmaceuticals Inc. appointed Edmund Harrigan to its board.

Harrigan most recently served as the senior vice president of worldwide safety and regulatory at Pfizer Inc.

He has 28 years of industry experience in clinical development, regulatory affairs and business development.

Bellicum CEO Rick Fair said Harrigan's addition will be "instrumental" as the company develops treatments for cancers and rare blood disorders.